Promoter-dependent activity on androgen receptor N-terminal domain mutations in androgen insensitivity syndrome

Rieko Tadokoro-Cuccaro, John Davies, Nigel P Mongan, Trevor Bunch, Rosalind S Brown, Laura Audi, Kate Watt, Iain J McEwan, Ieuan A Hughes

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Androgen receptor (AR) mutations are associated with androgen insensitivity syndrome (AIS). Missense mutations identified in the AR-N-terminal domain (AR-NTD) are rare, and clinical phenotypes are typically mild. We investigated 7 missense mutations and 2 insertion/deletions located in the AR-NTD. This study aimed to elucidate the pathogenic role of AR-NTD mutants in AIS and to use this knowledge to further define AR-NTD function. AR-NTD mutations (Q120E, A159T, G216R, N235K, G248V, L272F, and P380R) were introduced into AR-expression plasmids. Stably expressing cell lines were established for del57L and ins58L. Transactivation was measured using luciferase reporter constructs under the control of GRE and Pem promoters. Intrinsic fluorescence spectroscopy and partial proteolysis studies were performed for mutations which showed reduced activities by using a purified AR-AF1 protein. Pem-luciferase reporter activation was reduced for A159T, N235K, and G248V but not the GRE-luciferase reporter. Protein structure analysis detected no significant change in the AR-AF1 region for these mutations. Reduced cellular expression and transactivation activity were observed for ins58L. The mutations Q120E, G216R, L272F, P380R, and del57L showed small or no detectable changes in function. Thus, clinical and experimental analyses have identified novel AR-signalling defects associated with mutations in the structurally disordered AR-NTD domain in patients with AIS. © 2014 S. Karger AG, Basel.

Original languageEnglish
Pages (from-to)339-349
Number of pages11
JournalSexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
Volume8
Issue number6
Early online date6 Dec 2014
DOIs
Publication statusPublished - Jan 2015

Fingerprint

Androgen-Insensitivity Syndrome
Androgen Receptors
Mutation
Luciferases
Missense Mutation
Transcriptional Activation
Fluorescence Spectrometry
Proteolysis
Proteins
Plasmids

Keywords

  • androgen insensitivity syndrome
  • androgen receptor
  • N-terminal domain

Cite this

Promoter-dependent activity on androgen receptor N-terminal domain mutations in androgen insensitivity syndrome. / Tadokoro-Cuccaro, Rieko; Davies, John; Mongan, Nigel P; Bunch, Trevor; Brown, Rosalind S; Audi, Laura; Watt, Kate; McEwan, Iain J; Hughes, Ieuan A.

In: Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation, Vol. 8, No. 6, 01.2015, p. 339-349.

Research output: Contribution to journalArticle

Tadokoro-Cuccaro, Rieko ; Davies, John ; Mongan, Nigel P ; Bunch, Trevor ; Brown, Rosalind S ; Audi, Laura ; Watt, Kate ; McEwan, Iain J ; Hughes, Ieuan A. / Promoter-dependent activity on androgen receptor N-terminal domain mutations in androgen insensitivity syndrome. In: Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation. 2015 ; Vol. 8, No. 6. pp. 339-349.
@article{e526c953ed13431b841f639a45cc5e41,
title = "Promoter-dependent activity on androgen receptor N-terminal domain mutations in androgen insensitivity syndrome",
abstract = "Androgen receptor (AR) mutations are associated with androgen insensitivity syndrome (AIS). Missense mutations identified in the AR-N-terminal domain (AR-NTD) are rare, and clinical phenotypes are typically mild. We investigated 7 missense mutations and 2 insertion/deletions located in the AR-NTD. This study aimed to elucidate the pathogenic role of AR-NTD mutants in AIS and to use this knowledge to further define AR-NTD function. AR-NTD mutations (Q120E, A159T, G216R, N235K, G248V, L272F, and P380R) were introduced into AR-expression plasmids. Stably expressing cell lines were established for del57L and ins58L. Transactivation was measured using luciferase reporter constructs under the control of GRE and Pem promoters. Intrinsic fluorescence spectroscopy and partial proteolysis studies were performed for mutations which showed reduced activities by using a purified AR-AF1 protein. Pem-luciferase reporter activation was reduced for A159T, N235K, and G248V but not the GRE-luciferase reporter. Protein structure analysis detected no significant change in the AR-AF1 region for these mutations. Reduced cellular expression and transactivation activity were observed for ins58L. The mutations Q120E, G216R, L272F, P380R, and del57L showed small or no detectable changes in function. Thus, clinical and experimental analyses have identified novel AR-signalling defects associated with mutations in the structurally disordered AR-NTD domain in patients with AIS. {\circledC} 2014 S. Karger AG, Basel.",
keywords = "androgen insensitivity syndrome, androgen receptor, N-terminal domain",
author = "Rieko Tadokoro-Cuccaro and John Davies and Mongan, {Nigel P} and Trevor Bunch and Brown, {Rosalind S} and Laura Audi and Kate Watt and McEwan, {Iain J} and Hughes, {Ieuan A}",
year = "2015",
month = "1",
doi = "10.1159/000369266",
language = "English",
volume = "8",
pages = "339--349",
journal = "Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation",
issn = "1661-5433",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Promoter-dependent activity on androgen receptor N-terminal domain mutations in androgen insensitivity syndrome

AU - Tadokoro-Cuccaro, Rieko

AU - Davies, John

AU - Mongan, Nigel P

AU - Bunch, Trevor

AU - Brown, Rosalind S

AU - Audi, Laura

AU - Watt, Kate

AU - McEwan, Iain J

AU - Hughes, Ieuan A

PY - 2015/1

Y1 - 2015/1

N2 - Androgen receptor (AR) mutations are associated with androgen insensitivity syndrome (AIS). Missense mutations identified in the AR-N-terminal domain (AR-NTD) are rare, and clinical phenotypes are typically mild. We investigated 7 missense mutations and 2 insertion/deletions located in the AR-NTD. This study aimed to elucidate the pathogenic role of AR-NTD mutants in AIS and to use this knowledge to further define AR-NTD function. AR-NTD mutations (Q120E, A159T, G216R, N235K, G248V, L272F, and P380R) were introduced into AR-expression plasmids. Stably expressing cell lines were established for del57L and ins58L. Transactivation was measured using luciferase reporter constructs under the control of GRE and Pem promoters. Intrinsic fluorescence spectroscopy and partial proteolysis studies were performed for mutations which showed reduced activities by using a purified AR-AF1 protein. Pem-luciferase reporter activation was reduced for A159T, N235K, and G248V but not the GRE-luciferase reporter. Protein structure analysis detected no significant change in the AR-AF1 region for these mutations. Reduced cellular expression and transactivation activity were observed for ins58L. The mutations Q120E, G216R, L272F, P380R, and del57L showed small or no detectable changes in function. Thus, clinical and experimental analyses have identified novel AR-signalling defects associated with mutations in the structurally disordered AR-NTD domain in patients with AIS. © 2014 S. Karger AG, Basel.

AB - Androgen receptor (AR) mutations are associated with androgen insensitivity syndrome (AIS). Missense mutations identified in the AR-N-terminal domain (AR-NTD) are rare, and clinical phenotypes are typically mild. We investigated 7 missense mutations and 2 insertion/deletions located in the AR-NTD. This study aimed to elucidate the pathogenic role of AR-NTD mutants in AIS and to use this knowledge to further define AR-NTD function. AR-NTD mutations (Q120E, A159T, G216R, N235K, G248V, L272F, and P380R) were introduced into AR-expression plasmids. Stably expressing cell lines were established for del57L and ins58L. Transactivation was measured using luciferase reporter constructs under the control of GRE and Pem promoters. Intrinsic fluorescence spectroscopy and partial proteolysis studies were performed for mutations which showed reduced activities by using a purified AR-AF1 protein. Pem-luciferase reporter activation was reduced for A159T, N235K, and G248V but not the GRE-luciferase reporter. Protein structure analysis detected no significant change in the AR-AF1 region for these mutations. Reduced cellular expression and transactivation activity were observed for ins58L. The mutations Q120E, G216R, L272F, P380R, and del57L showed small or no detectable changes in function. Thus, clinical and experimental analyses have identified novel AR-signalling defects associated with mutations in the structurally disordered AR-NTD domain in patients with AIS. © 2014 S. Karger AG, Basel.

KW - androgen insensitivity syndrome

KW - androgen receptor

KW - N-terminal domain

U2 - 10.1159/000369266

DO - 10.1159/000369266

M3 - Article

C2 - 25500996

VL - 8

SP - 339

EP - 349

JO - Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation

JF - Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation

SN - 1661-5433

IS - 6

ER -